Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2750
Single User License Price INR 192500
Corporate User License Price USD 4500
Corporate User License Price INR 315000
Site License Price USD 3500
Site License Price INR 245000
Request a Quote

Report Title

Global Respiratory Drugs Market 2018-2024

Quote Request for License Type
License Type Price  
Single User License USD 2750
Site License USD 3500
Enterprise Wide License USD 4500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Global Respiratory Drugs Market 2018-2024


Quote Request for License Type
License Type Price  
Single User License USD 2750
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Global Respiratory Drugs Market 2018-2024

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Global Respiratory Drugs Market 2018-2024



Executive Summary

Respiratory disorders, which affect mechanisms of the respiratory system such as the lungs and airway, are a wide-ranging chronic disease with a diversity of underlying causes, ranging from inherited mutations to pathological inflammation. The respiratory disorders market is dominated by long-acting beta-agonist (LABA) and long-acting muscarinic antagonist (LAMA) therapies for chronic obstructive pulmonary disease (COPD) and asthma. These drugs stimulate muscles surrounding the bronchial tubes to suppress and open the airways.

Respiratory therapy area consists of signs that affect the lungs, bronchi, trachea, larynx, pharynx and nose in various ways, such as the scarring of lung tissue or the extreme production of mucus. Respiratory disease generally results in breathing difficulties, that can lead to troubles in sleep, wheezing, anxiety, and stress. During worse condition, shortness of breath (dyspnea) can limit physical activity, affecting both the quality of life and life expectancy of sufferers. The cause of respiratory disorders contrasts significantly across each indication and comprises factors such as environment, occupation, genetic predisposition, and aging.

Report Scope:

Report Category: Pharmacuticals / Healthcare

Therapy Type

Asthma

Chronic Obstructive Pulmonary Disease

Idiopathic Pulmonary Fibrosis

Cystic Fibrosis

End-user

Hospitals

Ambulatory Care

Others

Regions

North America

Europe

Asia Pacific

Rest of the World

Industry Outlook: Market Trends and Drivers, Restraints, and Opportunities

Table of Contents

1 Industry Outlook 9

1.1 Industry Overview 9

1.2 Total Addressable Market 10

1.3 Industry Trends 10

2 Report Outline 12

2.1 Report Scope 12

2.2 Report Summary 12

2.3 Research Methodology 13

2.4 Report Assumptions 13

3 Market Snapshot 15

3.1 Market Definition-Infoholic Research 15

3.2 Segmented Addressable Market (SAM) 15

3.3 Importance of Respiratory Care 15

3.4 Trends of Respiratory Drugs Market 16

3.5 Related Markets 17

3.5.1 Oncology (Cancer) Drugs 17

3.5.2 Active pharmaceutical ingredients (APIs) 17

3.5.3 Over the counter drugs (OTC) 18

3.5.4 Diabetes Drugs 18

4 Market Outline 20

4.1 Pipeline Products of Respiratory Drugs by Major Companies 20

4.2 Market Segmentation 23

4.3 Porter 5(Five) Forces 24

4.4 PEST Analysis 25

5 Market Characteristics 26

5.1 Market Dynamics of Respiratory Drugs Market 26

5.1.1 Drivers 27

5.1.1.1 Increasing Aging Population 27

5.1.1.2 Rising prevalence of respiratory diseases 28

5.1.1.3 High prevalence of tobacco smoking 28

5.1.2 Opportunities 28

5.1.2.1 Supportive initiatives from government and other organizations 28

5.1.2.2 Huge pool of undiagnosed chronic obstructive pulmonary disease population 28

5.1.3 Restraints 29

5.1.3.1 Expiry of patents for blockbuster drugs 29

5.1.3.2 Complex drug development process 30

5.1.4 DRO-Impact Analysis 30

5.1.5 Key Stakeholders 31

6 Application: Market Size and Analysis 33

6.1 Overview 33

6.2 Asthma 34

6.3 Chronic Obstructive Pulmonary Disease (COPD) 35

6.4 Cystic Fibrosis 36

6.5 Allergic Rhinitis 37

6.6 Others 38

7 Regions: Market Size and Analysis 40

7.1 Overview 40

7.2 North America 41

7.2.1 Overview 41

7.2.2 United States 42

7.2.3 Canada 43

7.3 Europe 43

7.3.1 Overview 43

7.3.2 United Kingdom 44

7.3.3 Germany 44

7.3.4 France 45

7.4 APAC 45

7.4.1 Overview 45

7.4.2 India 45

7.4.3 China 46

7.4.4 Japan 46

7.5 Rest of the World 47

7.5.1 Overview 47

7.5.2 Middle East 48

7.5.3 Brazil 49

7.5.4 Mexico 49

8 C

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

Novartis AG, GlaxoSmithKline plc, Astra Zenca PLC, F.Hoffmann-La Roche Ltd. , Vertex Pharmaceuticals Inc. Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd. Gilead Sciences Inc. Bayer AG, Pfizer Inc., Bristol-Myers Squibb Co. Merck & Co., Sanofi, Mallinckrodt plc


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person